eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank

vol. 43
Review paper

Rosai-Dorfman disease as a rare cause of cervical lymphadenopathy – case report and literature review

Aleksandra Miękus, Joanna Stefanowicz, Grażyna Kobierska-Gulida, Elżbieta Adamkiewicz-Drożyńska

(Centr Eur J Immunol 2018; 43 (3): 341-345)
Online publish date: 2018/10/30
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is a rare, benign clinical entity of unknown cause. RDD is characterised by the overproduction and accumulation of histiocytes, primarily in the lymph nodes, although it may affect every organ and system. It predominantly affects children and young adults. Typically, patients are in good general condition, with massive cervical lymphadenopathy and fever. In about 40% of cases extranodal localisation of RDD is diagnosed. In laboratory tests the most common abnormalities are increased erythrocyte sedimentation rate (ESR), leukocytosis with neutrophilia, normocytic anaemia, and hypergammaglobulinaemia. Histopathological examination remains the mainstay of diagnosis – lymph nodes have massive sinusoidal dilation, containing histiocytes positive for S-100 and CD68, and negative for CD1a. Most patients do not require treatment as spontaneous remissions are observed. We present a brief review of the literature and the case of a six-year-old boy with cervical lymphadenopathy diagnosed with RDD. So far, the patient has not required systemic treatment and has been kept under observation.

lymphadenopathy, Rosai-Dorfman disease, sinus histiocytosis

Rosai J, Dorfman RF (1969): Sinus histiocytosis with massive lymphadenopathy: A newly recognized benign clinicopathologic entity. Arch Pathol 87: 63-70.
Rosai J, Dorfman RF (1972): Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer 30: 1174-1188.
National Organization for Rare Disorders. Rosai-Dorfman Disease http://rarediseases.org/rare-diseases/rosai-dorfman-disease/ (accessed: February 10, 2016).
Dalia S, Sagatys E, Sokol L, Kubal T (2014): Rosai-Dorfman Disease. Tumor Biology, Clinical Features, Pathology and Treatment. Cancer Control 21: 322-327.
Histiocyte Society 2011; Rosai-Dorfman Disease Rewiev: Outline. https://www.histiocytesociety.org/document.doc?id=54 (accessed: February 10, 2016).
Lauwers GY, Perez-Atayde A, Dorfman RF, Rosai J (2000): The Digestive System Manifestations of Rosai-Dorfman Disease (Sinus Histiocytosis With Massive Lymphadenopahy): Review of 11 Cases. Hum Pathol 31: 380-385.
Levine PH, Jahan N, Murari P, et al. (1992): Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). JID 166: 291-295.
Mehraein Y, Wagner M, Remberger K, et al. (2006): Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations. J Clin Pathol 59: 1320-1326.
Tseng-Tong K, Tse-Ching C, Li-Yu L, Pei-Hsuan L (2009): IgG4-positive plasma cells in cutaneous Rosai-Dorfman disease: an additional immunohistochemical feature and possible relationship to IgG4-related sclerosing disease. J Cutan Pathol 36: 1069-1073.
Liping L, Perry AM, Wenfeng C, et al. (2013): Relationship Between Rosai-Dorfman Disease and IgG4-Related Disease. Study of 32 cases. Am J Clin Pathol 140: 395-402.
Maia RC, de Meis E, Romano S, et al. (2015): Rosai-Dorfman Disease: a report of eight cases in a tertiary care center and a review of the literature. Braz J Med and Biol Res 48: 6-12.
Cohen-Barak E, Rozenman D, Schafer J, et al. (2014): An unusual co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: report of a case and rewiev of the literature. Int J Dermatol 53: 558-563.
Wang KH, Cheng CJ, Hu CH, Lee WR (2002): Coexistence of localized Langerhans cell histiocytosis and cutaneous Rosai – Dorfman disease. Br J Dermatol 147: 770-774.
Patrizi A, Neri I, Bianchi F (2004): Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports. Dermatology 209: 57-61.
Moore JC, Zhao X, Nelson EL (2008): Concomitant sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman Disease) and diffuse large B-cell lymphoma: a case report. J Med Case Reports 2: 1-7.
Lu D, Estalilla OC, Manning Jr JT, Medeiros J (2000): Sinus Histiocytosis with Massive Lymphadenopathy and Malignant Lymphoma Involving the Same Lymph Node: A Report of Four Cases and Review of the Literature. Mod Pathol 13: 414-419.
Lewis Cooper S, Jenrette JM (2012): Rosai-Dorfman Disease: Management of CNS and Systemic Involvement. CAH&O 10: 199-202.
Morgan NV, Morris MR, Cangul H, et al. (2010): Mutations in SLC29A3, Encoding, and Equilibrative Nucleoside Transporter ENT3, Cause a Familial Histiocytosis Syndrome (Faisalabad Histiocytosis) and Familial Rosai-Dorfman Disease. PLoS Genetics 6: 1-9.
Brenn T, Calonje E, Granter S, et al. (2002): Cutaneous Rosai-Dorfman Disease Is a Distinct Clinical Entity. Am J Dermatopathol 24: 385-391.
Vemuganti GK, Naik MN, Honavar SG (2008): Rosai Dorfman disease of the orbit. J Hematol Oncol 28: 1-7.
Sandoval-Sus JD, Sandoval-Leon AC, Chapman JR, et al. (2014): Rosai-Dorfman Disease od the Central Nervous System. Report of 6 Cases and Review of the Literature. Medicine 93: 165-175.
Warrier R, Cahuhan A, Jewan Y, et al. (2012): Rosai-Dorfman Disease With Central Nervous System Involvement. CAH&O 10: 196-198.
Guven G, Ilgan S, Altun C, et al. (2007): Rosai – Dorfman disease of the parotid and submandibular glands:salivary gland scintigraphy and oral findings in two siblings. DMFR 36: 428-433.
Lao IW, Dong Y, Wang J (2014): Rosai-Dorfman disease of the pericardium: a case report and review of literature. Int J Clin Exp Pathol 7: 3408-3412.
Heidarian A, Anwar A, Haseeb MA, Gupta R (2017): Extranodal Rosai-Dorfman disease arising in the heart: clinical course and review of literature. Cardiovasc Pathol 4: 31:1-4.
Foucar E, Rosai J, Dorfman RF (1984): Sinus Histiocytosis With Massive Lymphadenopathy. An Analysis of 14 Deaths Occuring in a Patient Registry. Cancer 54: 1834-1840.
Pulsoni A, Anghel G, Falcucci P, et al (2002): Treatment of Sinus Histiocytosis With Massive Lymphadenopathy (Rosai-Dorfman Disease): Report of a Case and Literature Rewiev. Am J Hematol 69: 67-71.
McPherson CM, Brown J, Kim AW, DeMonte F (2006): Regression of intracranial Rosai-Dorfman disease following corticosteroid therapy. J Neurosurg 104: 840-844.
Aouba A, Terrier B, Vasiliu V, et al. (2006): Dramatic clinical efficacy of cladribine in Rosai-Dorfman disease and evolution of the cytokine profile: a new therapeutic approach. Haematologica 91: 144-145.
Simko SJ, Tran HD, Jones J, et al. (2014): Clofarabine salvage therapy in refractory multifocal histicytic disorders, incluging Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease. Pediatr Blood Cancer 61: 479-487.
Horneff G, Jurgens H, Hort W, et al. (1996): Sinus histiocytosis With Massive Lymphadenopathy (Rosai-Dorfman Disease): Response to Methotrexate and Mercaptopurine. Med Pediatr Oncol 27: 187-192.
Le Guenno G, Galicier L, Uro-Coste E, et al. (2012): Successful treatment with azathioprine of relapsing Rosai-Dorfman disease of the central nervous system. J Neurosurg 117: 486-489.
Konca C, Ozkurt ZN, Deger M, et al. (2008): Extranodal multifocal Rosai-Dorfman disease: response to 2-chlorodeoksyadenosine treatment. Int J Hematol 89: 58-62.
Lohr HF, Godderz W, Wolfe T, et al. (1995): Long-term Survival in a Patient with Rosai-Dorfman Disease Treated with Interferon-alfa. Eur J Cancer 31: 2427-2428.
Alqanatish JT, Houghton K, Bond M, et al. (2016): Rituximab Treatment in a Child with Rosai-Dorfman Disease and Systemic Lupus Erythematosus. J Rheumatol 37: 1783-1784.
Pagel JM, Lionberger J, Gopal AK, et al. (2007): Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Am J Hematol 82: 1121-1122.
Gebhardt C, Averbeck M, Paasch U, et al. (2009): A case of cutaneous Rosai-Dorfman disease refractory to imatinib therapy. Arch Dermatol 145: 571-574.
Mebazaa A, Trabelsi S, Denguezli M, et al. (2007): Extensive purely cutaneous Rosai-Dorfman disease responsive to acitretin. Int J Dermatol 46: 1208-1210.
Maklad AM, Bayoumi Y, Tunio M, et al. (2013): Steroid-Resistant Extranodal Rosai-Dorfman Disease of Cheek Mass and Ptosis Treated with Radiation Therapy. Case Rep Hematol ID: 428297.
Toguri D, Louie AV, Rizkalla K, et al. (2011): Radiotherapy for steroid-resistant laryngeal Rosai-Dorfman disease. Curr Oncol 18: 158-162.
Baildam EM, Ewing CI, D’Souza SW, Stevens RF (1992): Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to acyclovir. J R Soc Med 85: 179-180.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe